Global X Genomics Etf Technical Analysis

GNOM Etf  USD 9.83  0.01  0.10%   
As of the 22nd of November, Global X retains the Market Risk Adjusted Performance of (0.18), standard deviation of 1.61, and Risk Adjusted Performance of (0.10). Global X technical analysis makes it possible for you to employ historical prices and volume momentum with the intention to determine a pattern that calculates the direction of the entity's future prices. Please check out Global X Genomics information ratio and skewness to decide if Global X is priced fairly, providing market reflects its last-minute price of 9.83 per share.

Global X Momentum Analysis

Momentum indicators are widely used technical indicators which help to measure the pace at which the price of specific equity, such as Global, fluctuates. Many momentum indicators also complement each other and can be helpful when the market is rising or falling as compared to Global
  
Global X's Momentum analyses are specifically helpful, as they help investors time the market using mark points where the market can reverse. The reversal spots are usually identified through divergence between price movement and momentum.
Global X technical etf analysis exercises models and trading practices based on price and volume transformations, such as the moving averages, relative strength index, regressions, price and return correlations, business cycles, etf market cycles, or different charting patterns.
A focus of Global X technical analysis is to determine if market prices reflect all relevant information impacting that market. A technical analyst looks at the history of Global X trading pattern rather than external drivers such as economic, fundamental, or social events. It is believed that price action tends to repeat itself due to investors' collective, patterned behavior. Hence technical analysis focuses on identifiable price trends and conditions. More Info...

Global X Genomics Technical Analysis

Indicator
Time Period
Execute Indicator
The output start index for this execution was twenty with a total number of output elements of fourty-one. The Average True Range was developed by J. Welles Wilder in 1970s. It is one of components of the Welles Wilder Directional Movement indicators. The ATR is a measure of Global X Genomics volatility. High ATR values indicate high volatility, and low values indicate low volatility.

Global X Genomics Trend Analysis

Use this graph to draw trend lines for Global X Genomics. You can use it to identify possible trend reversals for Global X as well as other signals and approximate when it will take place. Remember, you need at least two touches of the trend line with actual Global X price movement. To start drawing, click on the pencil icon on top-right. To remove the trend, use eraser icon.

Global X Best Fit Change Line

The following chart estimates an ordinary least squares regression model for Global X Genomics applied against its price change over selected period. The best fit line has a slop of   0.02  , which may suggest that Global X Genomics market price will keep on failing further. It has 122 observation points and a regression sum of squares at 14.33, which is the sum of squared deviations for the predicted Global X price change compared to its average price change.

About Global X Technical Analysis

The technical analysis module can be used to analyzes prices, returns, volume, basic money flow, and other market information and help investors to determine the real value of Global X Genomics on a daily or weekly bases. We use both bottom-up as well as top-down valuation methodologies to arrive at the intrinsic value of Global X Genomics based on its technical analysis. In general, a bottom-up approach, as applied to this etf, focuses on Global X Genomics price pattern first instead of the macroeconomic environment surrounding Global X Genomics. By analyzing Global X's financials, daily price indicators, and related drivers such as dividends, momentum ratios, and various types of growth rates, we attempt to find the most accurate representation of Global X's intrinsic value. As compared to a bottom-up approach, our top-down model examines the macroeconomic factors that affect the industry/economy before zooming in to Global X specific price patterns or momentum indicators. Please read more on our technical analysis page.

Global X November 22, 2024 Technical Indicators

Most technical analysis of Global help investors determine whether a current trend will continue and, if not, when it will shift. We provide a combination of tools to recognize potential entry and exit points for Global from various momentum indicators to cycle indicators. When you analyze Global charts, please remember that the event formation may indicate an entry point for a short seller, and look at different other indicators across different periods to confirm that a breakdown or reversion is likely to occur.

Global X Genomics One Year Return

Based on the recorded statements, Global X Genomics has an One Year Return of -5.4%. This is 13.92% higher than that of the Global X Funds family and significantly lower than that of the Health category. The one year return for all United States etfs is notably higher than that of the company.
Although One Year Fund Return indicator can give a sense of overall fund short-term potential, it is recommended to look at mid and long term return measure before selecting a particular fund or ETF. The great way to validate fund short-term performance is to compare it with other similar funds or ETFs for the same 12 months interval.
When determining whether Global X Genomics is a strong investment it is important to analyze Global X's competitive position within its industry, examining market share, product or service uniqueness, and competitive advantages. Beyond financials and market position, potential investors should also consider broader economic conditions, industry trends, and any regulatory or geopolitical factors that may impact Global X's future performance. For an informed investment choice regarding Global Etf, refer to the following important reports:
Check out Risk vs Return Analysis to better understand how to build diversified portfolios, which includes a position in Global X Genomics. Also, note that the market value of any etf could be closely tied with the direction of predictive economic indicators such as signals in persons.
You can also try the My Watchlist Analysis module to analyze my current watchlist and to refresh optimization strategy. Macroaxis watchlist is based on self-learning algorithm to remember stocks you like.
The market value of Global X Genomics is measured differently than its book value, which is the value of Global that is recorded on the company's balance sheet. Investors also form their own opinion of Global X's value that differs from its market value or its book value, called intrinsic value, which is Global X's true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Global X's market value can be influenced by many factors that don't directly affect Global X's underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between Global X's value and its price as these two are different measures arrived at by different means. Investors typically determine if Global X is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Global X's price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.